Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of BD]
Country not established
- Devices
- 1
What Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of BD] makes
Bard Access Systems, Inc. manufactures the BD Intraosseous Infusion System, a medical device designed for administering fluids and medications directly into bone marrow in emergency or pediatric settings when intravenous access is difficult or impossible.
The BD Intraosseous Infusion System is classified as a Class II device in the U.S. and is listed under the FDA’s 510(k) clearance process. The company is based in the United States.
Catalogue
BD Intraosseous Infusion System Ref K203193
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd] have in the registry?
The registry currently lists 1 device for Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]. Devices recorded under merged duplicate company entries are counted once.
Which registries list Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]'s devices?
Among its 1 most recently registered device, Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd] has devices listed in FDA 510(k) (1 device).
What risk classes do Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd] in the registry?
The most recently registered devices listed for Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd] include BD Intraosseous Infusion System.